Pharmacy U people

I was always happy to work hard and give every opportunity the best chance of success. I enjoyed the challenge of business and of being successful in business. Even when things may not have worked out as expected, there was always the drive to look for other opportunities.

We all need purpose in our lives. My purpose is to help people and to keep paying attention. My colleagues and I remain committed to keeping independent community pharmacies in the hands of the next generation of entrepreneurs where possible.

The biggest challenge being an entrepreneur is the fact there is no playbook. You have to be willing to take a roller coaster ride that doesn't stop. There are no brakes, there's no getting off the ride, and you must commit to every up, down, loop, and turn.

Being an entrepreneur can sometimes be lonely, and there's a lot of pressure because many people depend on you. You want to do right by your partners, investors, employees, and family. The workload and tough situations can be stressful, which might not be the case if you didn't start the business.

What excites me about being a healthcare entrepreneur is the opportunity to help grow great Canadian organizations that make meaningful differences in the health and well-being of the communities they serve.

Helping others fulfill their potential is what excites me the most. It is why I love what I do. I challenge everyone within my team, not only at work, but also in their personal lives, to make today better than yesterday and tomorrow better than today.

I got into pharmacy school not realizing the vast array of opportunities that existed for pharmacists. The profession of pharmacy was interesting to me because it allowed me to help and connect with patients while still being able to manage and build a business.

I'm passionate about turning ideas into successful realities. Back in 1990, we recognized the crucial role pharmacists could play in patient education. We believed that providing them with a turnkey program, despite the need for financing from associations and pharma, would make a significant impact.